Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Shvidel

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Leukemia & Lymphoma|May 30, 2001
Primary effusion lymphoma (PEL) in HIV-negative patients--a distinct clinical entityA Klepfish, R Sarid, M Shtalrid, et al.
Leukemia & Lymphoma|April 12, 2003
Successful treatment of aggressive HIV-associated non-Hodgkin's lymphoma with combination chemotherapy, biotherapy with rituximab and HAART: presentation of a therapeutic optionA Klepfish, A Schattner, L Shvidel, et al.
Harefuah|August 1, 1997
[Budd-Chiari syndrome]S Goland, S D Malnick, L Shvidel, et al.
Leukemia|October 12, 2007
A novel cytogenetic aberration found in stem cell leukemia/lymphoma syndromeL Shvidel, E Sigler, E Vorst, et al.
Leukemia|July 6, 2007
Busulphan is safe and efficient treatment in elderly patients with essential thrombocythemiaL Shvidel, E Sigler, M Haran, et al.
Cancer Research|December 22, 1999
Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human-->mouse radiation chimeraA Shimoni, H Marcus, B Dekel, et al.
Oncogene|February 26, 2013
CD84 is a survival receptor for CLL cellsI Binsky-Ehrenreich, A Marom, M C Sobotta, et al.
Oncogene|July 26, 2016
CD84 mediates CLL-microenvironment interactionsA Marom, A F Barak, M P Kramer, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Leukemia & Lymphoma|May 30, 2001
Primary effusion lymphoma (PEL) in HIV-negative patients--a distinct clinical entityA Klepfish, R Sarid, M Shtalrid, et al.
Leukemia & Lymphoma|April 12, 2003
Successful treatment of aggressive HIV-associated non-Hodgkin's lymphoma with combination chemotherapy, biotherapy with rituximab and HAART: presentation of a therapeutic optionA Klepfish, A Schattner, L Shvidel, et al.
Harefuah|August 1, 1997
[Budd-Chiari syndrome]S Goland, S D Malnick, L Shvidel, et al.
Leukemia|October 12, 2007
A novel cytogenetic aberration found in stem cell leukemia/lymphoma syndromeL Shvidel, E Sigler, E Vorst, et al.
Leukemia|July 6, 2007
Busulphan is safe and efficient treatment in elderly patients with essential thrombocythemiaL Shvidel, E Sigler, M Haran, et al.
Cancer Research|December 22, 1999
Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human-->mouse radiation chimeraA Shimoni, H Marcus, B Dekel, et al.
Oncogene|February 26, 2013
CD84 is a survival receptor for CLL cellsI Binsky-Ehrenreich, A Marom, M C Sobotta, et al.
Oncogene|July 26, 2016
CD84 mediates CLL-microenvironment interactionsA Marom, A F Barak, M P Kramer, et al.
Pageof 3